COST ANALYSIS OF INSULIN DEGLUDEC IN COMPARISON WITH INSULIN GLARGINE U100 IN THE TREATMENT OF TYPE 1 DIABETES MELLITUS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM
May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.1286
https://www.valueinhealthjournal.com/article/S1098-3015(16)01354-1/fulltext
Section Title :
Diabetes/Endocrine Disorders - Cost Studies
Section Order :
623
First Page :
A200
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01354-1&doi=10.1016/j.jval.2016.03.1286